Journals / Ege Tıp Dergisi / 2009 / Cilt: 48 - Sayı: 3

Effects of pentoxifylline administration on vascular response in thoracic aorta from endotoxaemic rats

Endotoksemik sıçan torasik aortasındaki damar yanıtları üzerine pentoksifilin'in etkileri

Pages
159–166
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These results show that excessive NO production via iNOS induction caused by LPS and cytokines such as TNF-α play a key role in the vascular responsiveness seen in septic shock.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Tumor necrosis factor alpha (TNF-α) and nitric oxide (NO) are important mediators playing key roles in septic shock, a situation which is trigerred by endotoxin and other bacterial products.
📊
Key Findings & Data:In this study we investigated the effects of a phosphodiesterase inhibitor, pentoxifylline on the impaired vascular responses in septic shock, since the agent is known to inhibit TNF- α gene expression by increasing intracellular cAMP levels.
💡
Conclusion & Impact:These results show that excessive NO production via iNOS induction caused by LPS and cytokines such as TNF-α play a key role in the vascular responsiveness seen in septic shock.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: Tumor necrosis factor alpha (TNF-&#945;) and nitric oxide (NO) are important mediators playing key roles in septic shock, a situation which is trigerred by endotoxin and other bacterial products. In this study we investigated the effects of a phosphodiesterase inhibitor, pentoxifylline on the impaired vascular responses in septic shock, since the agent is known to inhibit TNF- &#945; gene expression by increasing intracellular cAMP levels. Material and Methods: Rats were injected intraperitoneally with 5 mg/kg LPS (E.Coli, serotype 055:B5) to induce endotoxic shock. 1 hour after LPS administration pentoxifylline (12.5, 25 mg/kg) was given by the same route. Contractile responses to phenylephrine, potassium chloride-KCl) and relaxant responses to acetylcholine-ACh and sodium nitroprusside- SNP were studied in the thoracic aortas 18 hours after LPS injection. Results: The contractile responses were decreased in septic shock as well as the endothelium-dependent, receptor-mediated vasorelaxant responses. These results show that excessive NO production via iNOS induction caused by LPS and cytokines such as TNF-&#945; play a key role in the vascular responsiveness seen in septic shock. Pentoxifylline (12.5 mg/kg) reversed the contractile responses (p<0.05) in the sepsis group, whereas it increased the ACh responses in both doses (12.5, 25 mg/kg)(p<0.05), which were decreased in the endotoxaemic animals. No differences were found between the groups in terms of the responses to the direct smooth muscle relaxant, sodium nitroprussid. Conclusion: These data obtained from the study consider that pentoxifylline administration might be a useful maneuver in the therapy of septic shock, which is a common cause of mortality.

Özet

Amaç: Endotoksin ve benzeri diğer bakteri ürünleri, mantar ve viruslar tarafından başlatılan olaylar dizisi olan septik şokta TNF-α ve NO başlıca rol oynayan medyatörlerdir. Çalışmada deneysel endotoksik şok modelinde, hücre içi gen transkripsiyonunu inhibe eden, fosfodiesteraz cAMP düzeyini artırarak TNF-α inhibitörü olan pentoksifilin'in sepsiste bozulmuş olan damar yanıtları üzerine olan etkileri araştırıldı. Yöntem ve Gereç: Sıçanlarda endotoksik şok oluşturmak üzere 5 mg/kg LPS (E.coli, serotip 055:B5) intraperitoneal yolla verildi. LPS injeksiyonundan 1 saat sonra pentoksifilin (12.5 ve 25 mg/kg) intraperitoneal yolla uygulandı. LPS injeksiyonundan 18 saat sonra izole edilen torasik aort halkalarında kasılma (fenilefrin, KCl) ve gevşeme (asetilkolin ve sodyum nitroprussid) yanıtları değerlendirildi. Bulgular: Sepsiste hem kasıcı yanıtların hem de endotel bağımlı, reseptör aracılı gevşeme yanıtlarının bozulduğunu göstermektedir. Sepsisteki damar yanıtlarındaki bu olumsuz değişikliklerde LPS'nin ve TNF-α gibi sitokinlerin neden olduğu iNOS indüksiyonu sonucu aşırı NO yapımının başlıca rol oynadığını göstermektedir. Pentoksifilin 12.5 mg/kg verilen sepsisli gruptaki bozulmuş fenilefrin kontraktil yanıtlarını düzeltti (p<0.05). Sepsis grubunda azalmış olan asetilkolin yanıtları pentoksifilin (12.5, 25 mg/kg) verilmesiyle düzeldi (p<0.05). Direkt düz kas gevşetici ajan olan sodyum nitroprussid yanıtlarında gruplar arasında farklılık gözlenmedi. Sonuç: Pentoksifilin ile elde ettiğimiz sonuçlar, bu ajanın önemli bir mortalite nedeni olan septik şokun tedavisinde umut verici olduğunu düşündürmektedir.

🔖

Cite This Article

ÇINAR, G. M., EROL, A. (2009). Effects of pentoxifylline administration on vascular response in thoracic aorta from endotoxaemic rats. Ege Tıp Dergisi, Cilt: 48 - Sayı: 3, 159–166. https://ajindex.com/articles/223309

References (18)

  1. Morrell MR, Micek ST, Kollef MH. The management of severe sepsis and septic shock. Infect Dis Clin North Am 2009; 23(3): 485-501
  2. Bone RC, Fisher CJ, Clemmer TP et al. Sepsis syndrome: A valid clinical entity. Crit Care Med 1989; 171:989-993
  3. Bone RC. The pathogenesis of sepsis. Ann Intern Med 1991; 115:457-469
  4. Johnston RB. Monocytes and macrophages. N Engl J Med 1988; 318: 747–752
  5. Boughton-Smith NJ, Hutcheson I and Whittle BJR. Relationship between PAF-acether and thromboxane A2 biosynthesis in endotoxin-induced intestinal damage in the rat. Prostaglandins 1989; 38: 319–331
  6. Beasley D. Interleukin-1 and endotoxin activate soluble guanylate cyclase in vascular smooth muscle. Am J Physiol 1990; 259: 38–44
  7. Tabor DR, Burchett SK and Jacobs RF. Enhanced production of monokines by canine alveolar macrophages in response to endotoxin-induced shock. Proc Soc Exp Biol Med1988; 187: 408–415
  8. Tracey KJ, Vlassara H and Cerami A. Cachectin/tumour necrosis factor. Lancet 1989; 1: 1122–1126
  9. Nathan C. Nitric oxide is a secrotory product of mammalian cells. FASEB J 1992; 6: 3051–3064
  10. Moncada S and Higgs EA. The -arginine-nitric oxide pathway. N Engl J Med 1993; 329 (27): 2002–2012
  11. Julou-Schaeffer G, Gray GA, Fleming I et al. Loss of vascular responsiveness induced by endotoxin involves -arginine pathway. Am J Physiol 1990; 259: H1038–H1043
  12. Michie HR, Manogue KR, Springs DR et al. Detection of circulating tumor necreosis factor after endotoxin administration. N Engl J Med 1988; 318:481-486
  13. Klosterhafen B, Horstmenn-Jungemann K, Vogel P et al. Time course of various inflammatory mediators during recurrent endotoxaemia. Biochem Pharmacol 1992; 43: 2103-2109
  14. Billiau A, Vandekerchove F. Cytokines and their interactions with other inflammatory mediators in the pathogenesis of sepsis and septic shock. Eur J Clin Invest 1991; 21: 559-573
  15. Giroir BP Mediators of septic shock: Nex approaches for interrupting the endogenous inflammatory cascade. Crit Care Med 1993; 21 (5): 780-789
  16. Doherty GM, Jensen JC, Alexander R et al. Pentoxifylline supression of tumor necrosis factor gene transcription. Surgery 1991; 110: 192-198
  17. Bernard C, Barnier P, Merval R et al. Pentoxifylline selectivity inhibits tumor necrosis factor synthesis in the arterial wall. J Cardivasc Pharmacol 1995; 25(Suppl. 2): S30-33
  18. Lerner MR, Kalla AK, Wilson MF et al. Pentoxifylline interferes with potential sources of free radical generation durin